Physician profile
Ilana Vance
NPI 1942746037
$2,112.90
in general payments reported to CMS, 2019-2025
14 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.60 · 2022: $26.71 · 2023: $192 · 2024: $620 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,054.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $588.99 | 2022-2025 | Unid_pass, Rialto Si Fusion System, Mazor X System |
| Carlsmed, INC. | $290.74 | 2025 | Aprevo |
| Highridge Medical LLC | $264.34 | 2024-2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $214.54 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Stryker Corporation | $206.70 | 2021-2024 | Tritanium, Capri Corpectomy Cage System |
| Alexion Pharmaceuticals, INC. | $179.93 | 2023-2024 | Soliris, Ultomiris |
| Orthofix Medical, INC. | $85.97 | 2025 | Spinal-Stim |
| Takeda Pharmaceuticals U.S.A., INC. | $80.78 | 2024-2025 | Hyqvia |
| Abbvie INC. | $75.72 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $37.43 | 2025 | Inbrija, Xeomin |
| Zimvie INC. | $34.85 | 2024 | |
| Sk Life Science, INC. | $22.37 | 2024 | |
| Neurelis, INC. | $15.62 | 2024 | Valtoco |
| Janssen Pharmaceuticals, INC | $14.92 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilana Vance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.